CLEARLINE CAPITAL LP – ADMA Biologics, Inc. Transaction History
CLEARLINE CAPITAL LP portfolio value:
$6.06M
portfolio value
CLEARLINE CAPITAL LP quarter portfolio value change:
+22.73%
quarter
ADMA Biologics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.46% | -421.96K shares | 288K | $2.43 | 2.49M |
| Q2 2022 | share | Decrease | -43.20% | -2.21M shares | -3.62M | $1.98 | 2.91M |
| Q1 2022 | share | Decrease | -19.10% | -1.21M shares | 448K | $1.83 | 5.13M |
| Q4 2021 | share | Increase | +749.65% | 5.60M shares | 8.10M | $1.32 | 6.35M |
| Q3 2021 | share | Decrease | -18.98% | -175.07K shares | -631K | $1.13 | 747.44K |
| Q2 2021 | share | Increase | +165.03% | 574.43K shares | 863K | $1.6 | 922.51K |
| Q1 2021 | share | Increase | 0.00% | 348.07K shares | 613K | $1.76 | 348.07K |